John A. Paulson, Chairperson of the Bausch Health board, acknowledged Goettler’s tenure with a brief statement of gratitude, wishing him success in his upcoming leadership position. The company confirmed that the resignation stems solely from this new career opportunity and is not rooted in any internal disagreements regarding Bausch Health’s current operations, policies, or corporate practices.
Michael Goettler Departs Bausch Health Board for Knoa Pharma CEO Role
Michael Goettler has resigned from the Bausch Health Companies Inc. Board of Directors, a move effective June 30, 2026. The departure follows his appointment as the new President and Chief Executive Officer of Knoa Pharma LLC, marking a significant transition for the veteran pharmaceutical executive.
When reusing this material a link to Money Talk is required.
Comments (0)
No comments yet. Be the first!